A GLANCE ON GSK HISTORYIn 1880, Burroughs Wellcome & Company was founded in London by American pharmacists Henry Wellcome and Silas Burroughs. Glaxo was founded in Bunnythorpe, New Zealand in 1904. Originally Glaxo was a baby food manufacturer processing local milk into a baby food by the same name: the product was sold in the 1930s under the slogan "glaxo builds bonny babies".
In 1830, John K. Smith opened its first pharmacy in Philadelphia. In 1865 mahlonKline joined the business which, 10 years later, became Smith, Kline & Co.
In 2000, glaxo welcome and SmithKline Beecham merged to form GlaxoSmithKline.
GSK IN PAKISTANGlaxoSmithKline Pakistan Limited was created on January 1st 2002 through the merger of SmithKline and French of Pakistan Limited, Beecham Pakistan (Private) Limited and Glaxo Wellcome (Pakistan) Limited- standing today as the largest pharmaceutical company in Pakistan.
and GSK PAKISTAN MISSION STATEMENT“Our mission is to improve the quality of human life by enabling people to do more, feel better live longer.”
GSK AREA OF BUSINESS
GSK Pakistan operates mainly in two industry segments: Pharmaceuticals (prescription drugs and vaccines) and consumer healthcare (over-the-counter- medicines, oral care and nutritional care).
GSK INTERNAL VIEW
GSK BALANCE SHEET VIEW FOR FIRST QUARTER OF 2010:
Total Current Assets 25,106,856
Total Fixed Assets 29,583,065Total Assets 66,117,643Total Liabilities 52,203,660Total Equity 13,913,982Total Liabilities & Stock Equity 66,117,643
GSK PAKISTAN LEADING PRODUCTPHARMACEUTICAL PRODUCT
PANADOL EXTRA
AUGMINTEN
GSK HEALTH CARE PRODUCT
Macleans
MACLEANS SENSITIVE
HORLICKS
SWOT ANALYSIS OF GSK PAKISTAN
Strengths
[*]Strong management team [*]Reputation management [*]sound capital base [*]good infrastructure [*]large market share [*]large highly skilled work force
Weaknesses
[*]Low market dominance [*]low online presence [*]Inconsistency of attractive promotions [*]High dependancy on only several products
Opportunities [*]Emerging markets and expansion abroad [*]Developing vaccines for persistent diseases
Threats
[*]Lower cost competitors or imports [*]counterfeit drugs being sold in competition with legitimate products
A GLANCE ON ABBOTT LABORTRIES HISTORY
Abbott Laboratories has its origin in the late 19th century in a small pharmaceutical operation run from the kitchen of a Chicago physician named Wallace Calvin Abbott. As did other physicians of the time, Dr. Abbott commonly prescribed morphine, quinine, strychnine, and codeine--all of which were liquid alkaloid extracts--for his patients. Because they existed only in a liquid form, these
drugs were prone to spoilage over timemitigating their effectiveness as treatment.
ABBOTT LABORTRIES OF PAKISTAN SHORT HISTORY
Abbott Pakistan is part of the global healthcare corporation of Abbott Laboratories, Chicago, USA.Abbott started operations in Pakistan as a marketing affiliate in 1948; the company has steadily expanded to comprise a work force of over 1500 employees. Currently two manufacturing facilities located at Landhi and Korangi in Karachi continue to use innovative technology to produce top quality pharmaceutical products.Abbott Pakistan has leadership in the field of Pain Management, Anesthesia, Medical Nutrition and Anti-Infectives.
MISSION STATEMENT AND VISION
Vision
“To be a premier healthcare
company in Pakistan”
Mission
“To deliver consistently superior
products and services which
contribute significantly to improvethe quality of life of the
consumers.”
ABBOTT PAKISTAN INTERNAL VIEW
Market ShareAbbott Pakistan achieved a market share of 6.1% as per IMS (Dec 2010, 12
Months) in the pharmaceutical and nutrition market (2009 market share: 5.8%).
ABBOTT PAKISTAN BALANCE SHEET VIEW FOR 2010ALL THE AMOUN IN RS:
Fixed Assets - property, plant
and equipment: 1,877,596
Other Non-Current Assets: 56,152
Current Assets: 3,856,673
Total Assets: 5790421
Issued, subscribed and paid-up capital: 979,003
Capital Reserves: 197,167
Revenue Reserves: 2,736,369
Total Equity: 3,912,539
Non-Current Liabilities: 115,182
ABBOTT LABORTRIES OF PAKISTAN`s MAIN PRODUCT
Abbott Labortries of Pakistan engaged in the following product catagery.
ABBOTT DIABATIES PRODUCT
Pharmaceutical Products
: brufen sirup
Nutritional Products
NUTRITIONAL PRODUCTS
Swot analysis of abbott labortries
Strengths, Weaknesses, Opportunities and Threats (SWOT)
Location of Factor TYPE OF FACTORFavorable Unfavorable
Internal Strengths
Continued uptake of Humira across autoimmune disorder market
Diverse lipid management portfolio
Blockbuster HIV franchise
Weaknesses
Patent exposure set to weaken prescription pharma portfolio
Narrow launch prospects largely restricted to follow-on medications
External Opportunities
Exciting prospect for lucrative vascular intervention segment in Xience V
Early stage pipeline programs in oncology, CNS
Threats
FTC investigation into generic defence strategies
New biologic launches for autoimmune
and immunology disorder market
COMPARISON ON THE BASIS OF SWOT ANALYSIS
Top Related